Human Antibody Fusion Proteins/Antibody Drug Conjugates in Breast and Ovarian Cancer

Publisher： Karger

E-ISSN： 1660-3818|44|5|303-310

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.44, Iss.5, 2017-09, pp. : 303-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody-cytokine fusion proteins: innovative weapons in the war against cancer

By Dela Cruz J.   Huang T.   Penichet M.   Morrison S.  

Clinical and Experimental Medicine, Vol. 4, Iss. 2, 2004-04 ,pp. : 57-64

Springer Publishing Company

Access to resources Recommend Favorite

Antibody-functionalized nano test tubes target breast cancer cells

By Buyukserin Fatih   Medley Colin D   Mota Miguel O   Kececi Kaan   Rogers Richard R   Tan Weihong   Martin Charles R  

Nanomedicine, Vol. 3, Iss. 3, 2008-06 ,pp. : 283-292

Future Medicine

Access to resources Recommend Favorite

Activated T-Cell and Bispecific Antibody Immunotherapy for High-Risk Breast Cancer

By  

Acta Haematologica, Vol. 105, Iss. 3, 2001-07 ,pp. : 130-136

Karger

Access to resources Recommend Favorite

Monoclonal Antibody Targeting of Ovarian Carcinoma

By  

Oncology, Vol. 55, Iss. 5, 1998-08 ,pp. : 435-446

Karger

Access to resources Recommend Favorite

Evaluation of a Novel Anti-Mucin 1 (MUC1) Antibody (PankoMab) as a Potential Diagnostic Tool in Human Ductal Breast Cancer; Comparison with Two Established Antibodies

By  

Oncology Research and Treatment, Vol. 32, Iss. 5, 2009-04 ,pp. : 238-244

Karger

Access to resources Recommend Favorite